Clinical trial
Blood Pressure and Glucose Lowering for the Prevention of Vascular Disease in…
NCT00145925 · The George Institute, Other · Completed
Key facts
| NCT number | NCT00145925 |
|---|---|
| Title | Blood Pressure and Glucose Lowering for the Prevention of Vascular Disease in High Risk Patients With Type 2 Diabetes |
| Official title | ADVANCE - Action in Diabetes and Vascular Disease: Preterax and Diamicron - MR Controlled Evaluation |
| Lead sponsor | The George Institute, Other |
| Collaborators | Institut de Recherches Internationales Servier University of Sydney National Health and Medical Research Council, Australia |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Perindopril-indapamide, Gliclazide MR-based glucose lowering |
| Enrollment | 11,140 |
| Start date | Jun 1, 2001 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Sep 5, 2005 |
| Last update posted | Apr 11, 2025 |
| Countries | Australia, Canada, China, Netherlands, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: